Maximus, Inc. (MMS) Stake Lessened by Fiera Capital Corp
Fiera Capital Corp reduced its stake in shares of Maximus, Inc. (NYSE:MMS) by 15.2% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 191,300 shares of the health services provider’s stock after selling 34,200 shares during the quarter. Fiera Capital Corp owned approximately 0.29% of Maximus worth $11,981,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently modified their holdings of the company. Van Berkom & Associates Inc. boosted its stake in shares of Maximus by 4.5% during the second quarter. Van Berkom & Associates Inc. now owns 1,150,713 shares of the health services provider’s stock valued at $72,069,000 after purchasing an additional 49,360 shares during the period. State of Tennessee Treasury Department boosted its stake in shares of Maximus by 50.0% during the second quarter. State of Tennessee Treasury Department now owns 60,000 shares of the health services provider’s stock valued at $3,758,000 after purchasing an additional 20,000 shares during the period. American International Group Inc. boosted its stake in shares of Maximus by 4.1% during the first quarter. American International Group Inc. now owns 166,652 shares of the health services provider’s stock valued at $10,366,000 after purchasing an additional 6,634 shares during the period. Geode Capital Management LLC boosted its stake in shares of Maximus by 6.9% during the first quarter. Geode Capital Management LLC now owns 496,870 shares of the health services provider’s stock valued at $30,905,000 after purchasing an additional 31,918 shares during the period. Finally, OppenheimerFunds Inc. boosted its stake in shares of Maximus by 19.5% during the first quarter. OppenheimerFunds Inc. now owns 11,010 shares of the health services provider’s stock valued at $685,000 after purchasing an additional 1,793 shares during the period. 97.23% of the stock is owned by hedge funds and other institutional investors.
Shares of Maximus, Inc. (MMS) opened at 63.58 on Friday. The stock has a market capitalization of $4.12 billion, a price-to-earnings ratio of 20.38 and a beta of 1.37. Maximus, Inc. has a 1-year low of $43.69 and a 1-year high of $64.97. The company has a 50-day moving average of $60.72 and a 200-day moving average of $61.45.
Maximus (NYSE:MMS) last announced its earnings results on Thursday, August 3rd. The health services provider reported $0.79 EPS for the quarter, beating analysts’ consensus estimates of $0.76 by $0.03. Maximus had a return on equity of 25.08% and a net margin of 8.43%. The company had revenue of $600.40 million during the quarter, compared to analysts’ expectations of $614.12 million. During the same period last year, the business posted $0.79 EPS. Maximus’s revenue for the quarter was down 2.7% on a year-over-year basis. On average, equities research analysts expect that Maximus, Inc. will post $3.13 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Thursday, August 31st. Investors of record on Tuesday, August 15th were issued a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date was Friday, August 11th. Maximus’s dividend payout ratio (DPR) is 5.73%.
A number of analysts have recently issued reports on the stock. BidaskClub lowered shares of Maximus from a “buy” rating to a “hold” rating in a research note on Thursday, July 13th. Maxim Group set a $66.00 target price on shares of Maximus and gave the company a “hold” rating in a research note on Thursday, August 3rd. KeyCorp reissued a “sector weight” rating on shares of Maximus in a research note on Thursday, May 25th. Zacks Investment Research raised shares of Maximus from a “sell” rating to a “hold” rating in a research note on Wednesday, July 26th. Finally, Canaccord Genuity lowered shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 target price for the company. in a research note on Tuesday, July 4th. One investment analyst has rated the stock with a sell rating and nine have assigned a hold rating to the company’s stock. Maximus has an average rating of “Hold” and a consensus price target of $62.43.
COPYRIGHT VIOLATION WARNING: This news story was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/09/16/maximus-inc-mms-stake-lessened-by-fiera-capital-corp.html.
In related news, General Counsel David Francis sold 2,000 shares of the firm’s stock in a transaction dated Friday, August 18th. The stock was sold at an average price of $58.89, for a total transaction of $117,780.00. Following the completion of the transaction, the general counsel now directly owns 13,716 shares in the company, valued at approximately $807,735.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Raymond B. Ruddy sold 25,000 shares of the firm’s stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $62.68, for a total value of $1,567,000.00. Following the transaction, the director now owns 227,552 shares of the company’s stock, valued at $14,262,959.36. The disclosure for this sale can be found here. Insiders have sold a total of 125,403 shares of company stock valued at $7,645,251 over the last 90 days. 3.10% of the stock is currently owned by company insiders.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.